Actavis Malta
Home
About Us
Our Commitment
Products
Press
Careers
Remirta
Generic Name:
Mirtazapine 15mg, 30mg tablets
Active Ingredient:
Mirtazapine 15mg, 30mg orodispersible tablets
Group:
Central Nervous System
ATC code:
N06A X11
Application:
Oral administration
Dosage Form and Strength:
Pack of 30 orodispersible tablets in blisters of 6 tablets
Description:
Mirtazapine is a presynaptic α2 antagonist, which increases noradrenergic and serotonergic neurotransmission in the central nervous system. Mirtazapine is used to treat Major depressive episodes. The tablet should be placed on the tongue with dry hands where it is rapidly dissolved. Orodispersible tablets should be taken with water and with or without food.
SPC document
Remirta 15mg, 30mg (PDF, 119KB)
Products
Home
Sitemap
Privacy policy
Site terms
BLB016 Bulebel Industrial Estate Zejtun ZTN 3000 • Phone (+356) 21 693 533 • Fax (+356) 21 693 604 •
info@actavis.com.mt
© Actavis 2013